At this time, you can't buy Rybix ODT (orally disintegrating tramadol) in generic form. The drug's next patent is set to expire in April 2017, and it's possible that a generic version could be introduced after this date. It's important to note that tramadol is the active ingredient in Rybix ODT, which is not the same as a generic version.
Can I Buy Generic Rybix ODT?
This medication is no longer available, as it has been discontinued by the manufacturer. Other tramadol products are still available.
Rybix™ ODT (orally disintegrating tramadol) is a prescription pain medication. It comes in the form of tablets that dissolve rapidly on the tongue with no need for water. It is approved for moderate-to-moderately severe chronic pain in adults.
Brand-name Rybix ODT is made by Ethypharm S.A. for Victory Pharma, Inc. There are no generic versions available at this time, as the medication is protected by patents that prevent any generic Rybix ODT from being made.
When Will Generic Rybix ODT Be Available?
Although the first patent for Rybix ODT already expired in March 2013, no generic versions are available. This suggests that another, later-expiring patent may still be providing protection for the drug. The next patent is set to expire in April 2017. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten the exclusivity period of Rybix ODT. This could include such things as lawsuits or other patents for specific uses of the drug. Once the patent expires, there may be several companies that manufacture a generic Rybix ODT drug.
Is Tramadol a Generic Version of Rybix ODT?
No -- tramadol is the active ingredient in Rybix ODT (as well as a few other medications) but is not a generic version of it. What can be confusing is that the active ingredient of any drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 13, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click